Monterey Bio Acquisition Corp (MTRY) Financials

$11.14

$0.00 (0.00%)

As on 29-Nov-2023 09:30EDT

Market cap

$48 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	3.27	2.04	0.52	--	--	--
Gross Profit	-3.27	-2.04	-0.52	--	--	--
Operating Expenses	2.16	2.04	0.52	--	--	--
Operating Profit (EBIT)	-2.16	-2.04	-0.52	--	--	--
Other Income	0.88	0.88	-0.06	--	--	--
Profit before Tax	-1.00	-1.16	-0.58	--	--	--
Provision for Tax	0.19	0.12	0.00	--	--	--
Profit after Tax (Net Income)	-1.19	-1.27	-0.58	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-1.19	-1.27	-0.58	0.00	--	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	19.44	19.74	117.07	0.02	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.70	0.29	--	--	--
Current Liabilities	2.98	1.68	0.29	0.00	--	--
Total Liabilities	25.39	21.42	117.35	0.03	--	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	21.87	21.03	116.42	--	--	--
Current Assets	0.55	0.39	0.93	0.03	--	--
Total Assets	25.39	21.42	117.35	0.03	--	--
Total Debt*	1.92	--	--	--	--	--
Net Current Assets	-2.43	-1.29	0.64	0.02	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-1.00	-0.94	-0.94	--	--
Cash Flow from Investing Activities	--	96.00	-116.15	-116.15	--	--
Cash from Financing Activities	--	-95.36	117.58	0.06	--	--
Net Cash Inflow / Outflow	--	-0.37	0.49	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.40	-0.42	-0.19	--	--	--
Cash EPS ($)	--	-0.42	-0.19	--	--	--
Adjusted Book Value ($)	--	6.58	39.02	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.33	-0.31	--	--	--
Free Cash Flow per Share ($)	--	-0.33	-0.31	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-1.86	-0.99	--	--	--
ROE (%)	-6.06	-1.86	-0.99	--	--	--
ROA (%)	-1.66	-1.84	-0.99	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-134.63	-144.58	962.56	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-8.55	-289.95	-21,686.75	--	--	--
Net Profit Growth (%)	-324.20	-119.31	--	--	--	--
EPS Growth (%)	-6.12	-1.19	--	--	--	--
Book Value Growth (%)	-83.32	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-24.73	-50.87	--	--	--
Price / Book Value	2.49	1.60	0.25	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-24.45	--	-63.11	--	--	--
Close Price ($)	10.92	10.50	9.85	--	--	--
High Price ($)	11.04	10.50	9.90	--	--	--
Low Price ($)	10.02	9.85	9.85	--	--	--
Market Cap ($ Cr)	48.30	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	0.10	--	--	--	--	--
Current Ratio	0.18	0.23	3.25	25.00	--	--
Quick Ratio	0.18	--	--	--	--	--
Interest Coverage	-0.03	-2.31	-4.25	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	146.16	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.